Current ATNF stock forecast models suggest a resistance at $0.85 and support around $0.60, with biotech indices trending upward in April, creating potential momentum spillover. Aug 12, 2025 · Balancing debts and strategizing liquidity, the stakes forecast fresh beginnings constructed on digital and fiscal foresight. In their pursuit of invigorated growth, ATNF becomes more than a stock ; it is the embodiment of transformative possibilities. This is stock news, not investment advice. 180 Life Sciences (NASDAQ:ATNF) , operating as ETHZilla, has announced significant cryptocurrency holdings of 82,186 Ethereum (ETH) acquired at an average price of $3,806.71, currently valued at approximately $349 million . The company also maintains $238 million in USD cash equivalents . Updated ATNF stock forecast sentiment remains cautious, as market makers adjust spreads amid unpredictable news flows in the biotech innovation chain.
